Publication: 3079

Publication: 3079

CALGB/Alliance 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) (+/- carboplatin (Cb) and bevacizumab (Bev)) in triple-negative breast cancer (TNBC)

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 37 (15 suppl) 591

Meeting Instance:: ASCO 2019
Year:: 2019
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3429 3660

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Genentech
Grants:: U10CA180821, U10CA180882; U10CA180888 (SWOG);

Corr. Author:
Authors:: William M Sikov Mei-Yin C Polley Erin L Twohy Charles M Perou Baljit Singh Donald A Berry Sara M Tolaney George Somlo Elisa R Port Cynthia Ma Charles Kuzma Eleftherios Mamounas Mehra Golshan Jennifer R Bellon Deborah Collyar Olwen M Hahn Clifford A Hudis Eric P Winer Ann Partridge Lisa A Carey

Networks:: CA043, FL086, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NY021, RI005, SCOR

Study: CALGB-40603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: